Rabu, 27 Oktober 2010

Mesothelioma treatment regimen results in patients survive five years


Promising results after treatment of a young woman who was diagnosed with mesothelioma it is hoped, may encourage some in the medical community as an important step taken to develop a potential cure for the disease. Karen Grant was diagnosed with mesothelioma develop in relatively young age of 29 years for the majority of mesothelioma because of its long latency period. After learning of the disease, Grant is in the International Programme for mesothelioma to be at the Brigham and Women's Hospital in Boston, led the was by Dr. David J. Sugarbaker, who is also head of hospitals in the Department of Thoracic Surgery and Professor treated Richard Wilson for Surgical Oncology at Harvard Medical School.

After the declared fit for surgery began, Dr. Sugarbaker and his staff an aggressive form of treatment that two extrapleural pneumonectomy for mesothelioma cancer included from each lung, the laser surgery on cancer cells that have been overlooked kill, Additional, the bath solution both lungs Hot chemotherapy and other forms the treatment and rehabilitation.

The results of the treatment regime has acted Sugar Bakers Dr. Grant over the past five years have been simply outstanding. Now in his mid-lung scans 30 and tests showed no recurrence of Grant of any type of cancer. This is particularly impressive, because many mesothelioma patients with the disease within one year after diagnosis, mesothelioma and cancer cells often die to come back about 2-3 years after the first treatment for people both time.

Despite the success are Dr. Sugarbaker and his team are trying their research, different ways to kill mesothelioma cancer cells and treatment of patients with the disease better. However, said Dr. Pasi Janne of Dana-Farber Cancer Institute, the treatment was developed by Dr. Sugarbaker's historic step, could be an important step towards a possible cure.

0 komentar:

Posting Komentar

Related Posts Plugin for WordPress, Blogger...
h